Detalles de la búsqueda
1.
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.
Kidney Int
; 104(4): 840-850, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37391040
2.
Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe.
Transpl Int
; 35: 10225, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36017158
3.
Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models.
Int J Mol Sci
; 23(15)2022 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35955542
4.
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial.
Am J Transplant
; 21(8): 2833-2845, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33725408
5.
Functional immune monitoring of BK Virus and donor-specific T-cell effector immune responses to guide treatment decision-making after kidney transplantation; an illustrative case report and literature review.
Transpl Infect Dis
; 23(2): e13495, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070461
6.
Dual and Opposite Costimulatory Targeting with a Novel Human Fusion Recombinant Protein Effectively Prevents Renal Warm Ischemia Reperfusion Injury and Allograft Rejection in Murine Models.
Int J Mol Sci
; 22(3)2021 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33530581
7.
Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial.
Clin Infect Dis
; 71(9): 2375-2385, 2020 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32076718
8.
Noncanonical immunomodulatory activity of complement regulator C4BP(ß-) limits the development of lupus nephritis.
Kidney Int
; 97(3): 551-566, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31982108
9.
Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.
Am J Transplant
; 19(2): 368-380, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30085394
10.
ANRIL as a genetic marker for cardiovascular events in renal transplant patients - an observational follow-up cohort study.
Transpl Int
; 2018 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29722077
11.
The Costimulatory Pathways and T Regulatory Cells in Ischemia-Reperfusion Injury: A Strong Arm in the Inflammatory Response?
Int J Mol Sci
; 19(5)2018 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29693595
12.
Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Kidney Int
; 92(1): 201-213, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28274484
13.
The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation.
Pharmacogenet Genomics
; 27(9): 313-322, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28704257
14.
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.
Am J Kidney Dis
; 69(5): 587-594, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27889299
15.
A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
J Am Soc Nephrol
; 27(8): 2487-94, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26647424
16.
Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
Am J Kidney Dis
; 67(4): 648-59, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26717860
17.
Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.
Kidney Int
; 88(4): 874-87, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26176829
18.
CD154-CD40 T-cell co-stimulation pathway is a key mechanism in kidney ischemia-reperfusion injury.
Kidney Int
; 88(3): 538-49, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25993320
19.
Development of a population PK model of tacrolimus for adaptive dosage control in stable kidney transplant patients.
Ther Drug Monit
; 37(2): 246-55, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25254416
20.
Renal allograft performance in immigrant transplant recipients.
Transpl Int
; 33(11): 1387-1389, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32668492